Asset Dedication LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.67M | Sell |
7,594
-3,378
| -31% | -$1.2M | 0.19% | 82 |
|
|
2025
Q4 | $3.59M | Sell |
10,972
-461
| -4% | -$146K | 0.24% | 64 |
|
|
2025
Q3 | $3.23M | Sell |
11,433
-184
| -2% | -$53.4K | 0.22% | 72 |
|
|
2025
Q2 | $3.24M | Buy |
11,617
+409
| +4% | +$116K | 0.24% | 62 |
|
|
2025
Q1 | $3.49M | Buy |
11,208
+63
| +0.6% | +$18.6K | 0.28% | 59 |
|
|
2024
Q4 | $2.9M | Sell |
11,145
-5,808
| -34% | -$1.72M | 0.23% | 68 |
|
|
2024
Q3 | $5.46M | Sell |
16,953
-2,138
| -11% | -$699K | 0.37% | 52 |
|
|
2024
Q2 | $5.97M | Buy |
19,091
+1,654
| +9% | +$486K | 0.41% | 52 |
|
|
2024
Q1 | $4.97M | Sell |
17,437
-175
| -1% | -$51.2K | 0.37% | 56 |
|
|
2023
Q4 | $5.07M | Buy |
17,612
+1,499
| +9% | +$408K | 0.41% | 51 |
|
|
2023
Q3 | $4.33M | Buy |
16,113
+2,156
| +15% | +$538K | 0.37% | 58 |
|
|
2023
Q2 | $3.12M | Buy |
13,957
+518
| +4% | +$120K | 0.27% | 77 |
|
|
2023
Q1 | $3.24M | Buy |
13,439
+39
| +0.3% | +$9.57K | 0.3% | 70 |
|
|
2022
Q4 | $3.54M | Buy |
13,400
+1,122
| +9% | +$301K | 0.36% | 58 |
|
|
2022
Q3 | $2.75M | Buy |
12,278
+347
| +3% | +$84.1K | 0.3% | 69 |
|
|
2022
Q2 | $2.88M | Buy |
11,931
+1,259
| +12% | +$309K | 0.43% | 45 |
|
|
2022
Q1 | $2.56M | Buy |
10,672
+1,486
| +16% | +$341K | 0.29% | 78 |
|
|
2021
Q4 | $2.04M | Buy |
9,186
+963
| +12% | +$203K | 0.25% | 92 |
|
|
2021
Q3 | $1.74M | Sell |
8,223
-1,056
| -11% | -$243K | 0.23% | 97 |
|
|
2021
Q2 | $2.25M | Buy |
9,279
+2,495
| +37% | +$614K | 0.34% | 74 |
|
|
2021
Q1 | $1.66M | Sell |
6,784
-1,133
| -14% | -$270K | 0.38% | 72 |
|
|
2020
Q4 | $1.82M | Buy |
7,917
+1,085
| +16% | +$250K | 0.36% | 77 |
|
|
2020
Q3 | $1.75M | Buy |
6,832
+540
| +9% | +$134K | 0.39% | 70 |
|
|
2020
Q2 | $1.48M | Buy |
6,292
+231
| +4% | +$52.7K | 0.4% | 67 |
|
|
2020
Q1 | $1.23M | Sell |
6,061
-171
| -3% | -$37.4K | 0.36% | 76 |
|
|
2019
Q4 | $1.5M | Buy |
6,232
+683
| +12% | +$151K | 0.42% | 71 |
|
|
2019
Q3 | $1.07M | Buy |
5,549
+36
| +0.7% | +$6.91K | 0.35% | 83 |
|
|
2019
Q2 | $1.02M | Buy |
5,513
+268
| +5% | +$48K | 0.33% | 81 |
|
|
2019
Q1 | $991K | Sell |
5,245
-12
| -0.2% | -$2.29K | 0.34% | 85 |
|
|
2018
Q4 | $1.02M | Sell |
5,257
-418
| -7% | -$81.5K | 0.42% | 76 |
|
|
2018
Q3 | $1.18M | Buy |
5,675
+400
| +8% | +$78.8K | 0.44% | 67 |
|
|
2018
Q2 | $971K | Buy |
5,275
+24
| +0.5% | +$4.25K | 0.33% | 85 |
|
|
2018
Q1 | $900K | Buy |
5,251
+1,350
| +35% | +$248K | 0.45% | 67 |
|
|
2017
Q4 | $679K | Buy |
3,901
+1,203
| +45% | +$213K | 0.27% | 94 |
|
|
2017
Q3 | $503K | Sell |
2,698
-38
| -1% | -$6.73K | 0.24% | 92 |
|
|
2017
Q2 | $473K | Sell |
2,736
-88
| -3% | -$14.3K | 0.24% | 100 |
|
|
2017
Q1 | $464K | Sell |
2,824
-69
| -2% | -$11.5K | 0.25% | 94 |
|
|
2016
Q4 | $422K | Sell |
2,893
-231
| -7% | -$34.8K | 0.24% | 97 |
|
|
2016
Q3 | $526K | Buy |
3,124
+351
| +13% | +$59.4K | 0.33% | 91 |
|
|
2016
Q2 | $422K | Sell |
2,773
-143
| -5% | -$22.2K | 0.29% | 95 |
|
|
2016
Q1 | $437K | Sell |
2,916
-67
| -2% | -$9.95K | 0.32% | 87 |
|
|
2015
Q4 | $484K | Buy |
+2,983
| New | +$469K | 0.32% | 88 |
|
Other funds holding AMGN
VCM
VPM
Asset Dedication LLC's AMGN Position: Q1 2026 in Review
Asset Dedication LLC reduced its Amgen (AMGN) stake by 31% in Q1 2026, selling an estimated $1.2M and leaving 7,594 shares worth $2.67M. The position accounts for 0.19% of the portfolio, ranked #82.
Asset Dedication LLC first reported a position in AMGN in Q4 2015 and has held it in 42 quarters since. The position peaked at $5.97M in Q2 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Asset Dedication LLC held 7,594 shares of Amgen worth $2.67M as of Q1 2026.
- Asset Dedication LLC sold 3,378 Amgen shares in Q1 2026, an estimated $1.2M.
- Amgen made up 0.19% of Asset Dedication LLC's portfolio in Q1 2026, its #82 holding.
- Asset Dedication LLC first reported a position in Amgen in Q4 2015 and has held it in 42 quarters since.
- Asset Dedication LLC's Amgen position peaked at $5.97M in Q2 2024.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Asset Dedication LLC's 13F filing for Q1 2026, filed 29 May 2026.